Navigation Links
SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor
Date:12/17/2007

DUBLIN, Calif., December 17 /PRNewswire-FirstCall/ -- SuperGen, Inc. (Nasdaq: SUPG) today announced that investigators have dosed the first patient in a multi-arm Phase 1b clinical trial of MP470, a novel, oral, multi-targeted tyrosine kinase inhibitor (TKI). The trial will evaluate MP470 in combination with several standard of care chemotherapy regimens, including carboplatin/paclitaxel, carboplatin/etoposide, docetaxel, topotecan, and erlotinib. The trial is expected to enroll up to 105 patients at five study centers.

The Phase 1b trial is an open label, dose-escalation study designed to assess the safety and tolerability of MP470 in combination with these standard of care chemotherapy regimens, and to define the dose of MP470 to advance into Phase 2 combination studies. Additionally, the Company will assess pharmacokinetic and biomarker data from the study. The trial is open to chemotherapy nave or treatment experienced patients with a variety of solid tumors irrespective of previous lines of therapy.

"MP470 shows significant preclinical synergy with all of these well established chemotherapy agents. Its preclinical toxicology profile, as well as preliminary safety data from our ongoing Phase 1 trial suggests it will be safe to combine it with these regimens," said Dr. Gregory Berk, Chief Medical Officer of SuperGen. "In preclinical models, MP470 also suppresses Rad51, a protein that plays a key role in the mechanism of resistance to these treatments. We believe this offers the potential for MP470 to improve on the efficacy of these therapies. The multi-arm, Phase 1b design allows us to accelerate the clinical development of MP470 which will expedite the timeline to our Phase 2 program."

About MP470

MP470 is
'/>"/>

SOURCE SuperGen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. SuperGens Novel Hypomethylating Agent Highlighted at AACR Plenary Session
2. Data Support use of SuperGens CLIMB Technology in Lead Development and Optimization
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
11. Biopure Reports on Meeting with the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015   Surefire Medical, Inc. today ... the Surefire Infusion System with an end hole ... liver cancer, using the Surefire resulted in statistically ... and with significantly decreased uptake in normal liver ... Society of Interventional Radiology (SIR) meeting ...
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... "Global POC Diagnostics Market 2015-2019" report to ... the Global POC Diagnostics market to grow at a ... POC diagnostics are IVD devices and tools ... laboratory setting. The use of these devices helps in ...
(Date:3/3/2015)... Calif. , March 3, 2015 /PRNewswire/ ... Council today recognized world-class manufacturing companies and ... Manufacturing Leadership Awards. Logo - ... world of intensifying global competition and accelerating, ... have distinguished themselves by embracing breakthrough innovation ...
Breaking Medicine Technology:Clinical Trial Comparing the Surefire Infusion Device to an End Hole Catheter Finds Surefire Increases Tumor Uptake and Decreases Non-Target Embolization In Every Patient, Multiple Liver Cancer Types 2Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 22015 Manufacturing Leadership Award Winners Announced 22015 Manufacturing Leadership Award Winners Announced 32015 Manufacturing Leadership Award Winners Announced 42015 Manufacturing Leadership Award Winners Announced 52015 Manufacturing Leadership Award Winners Announced 6
... , PLYMOUTH, Mich. and BATON ROUGE, ... a privately held biopharmaceutical company working to discover, develop ... announced that TransGenRx, a global leader in transgenic technology, ... company,s research efforts targeting HDL therapies for the treatment ...
... , June 21, 2010 PolyTouch Medical Ltd., ... that it has received broad FDA 510(k) clearance,to commercialize PatchAssist(TM). ... rapid delivery and placement of,soft tissue prosthetics for a variety ... , , ...
Cached Medicine Technology:TransGenRx Protein Therapeutics Technology to Support Research Related to Protein-Based HDL Therapies at Esperion Therapeutics 2TransGenRx Protein Therapeutics Technology to Support Research Related to Protein-Based HDL Therapies at Esperion Therapeutics 3PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects 2PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects 3
(Date:3/3/2015)... NY (PRWEB) March 03, 2015 Daylight Savings ... spring. Sanjeev Kothare, MD, has tips for parents. , Parents ... March 8 at 2:00 a.m. when they set their clocks ... you wake up that day -- one hour earlier -- ... That’s why parents should start thinking about “sleep hygiene” for ...
(Date:3/3/2015)... 2015 DePuy Pinnacle hip lawsuits ... of the artificial hip system caused recipients to ... forward in the federal multidistrict litigation underway in ... to the most recent Master Case List issued ... Pinnacle hip replacement lawsuits are now pending in ...
(Date:3/3/2015)... 03, 2015 The combinatorial, multi-gene ... antidepressant treatment outcomes for patients with depression, and ... of the individual genes that comprise the test, ... the Mayo Clinic and Assurex Health, and published ... The proprietary technology of the GeneSight Psychotropic test ...
(Date:3/3/2015)... The Calistoga Chamber of Commerce announces a brand new ... Friday, March 27, through Sunday, March 29, 2015. The weekend-long ... restaurant and bar crawl, lodging and spa specials, yoga and ... and older. , A variety of lodging and spa properties ... by offering Mudder of All Weekends packages featuring special room ...
(Date:3/3/2015)... Introducing 3D Digital Technologies to their ... leader in Digital Dentistry. Acute precision in ... replicas, leaving no room for error during the ... are able to significantly reduce “chair time” and ... quality while reducing labor and material costs proving ...
Breaking Medicine News(10 mins):Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 2Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 3Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 2Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 3
... in Afghanistan and Iraq, studies have shown that the incidence of ... Harvard researcher credits the drop, in part, to new efforts by ... develop the disorder receive the best treatment available. In ... Science , Professor of Psychology Richard J. McNally says there is ...
... most of the research on diet and obesity focuses on what ... should be given to when people eat. U.S. researchers ... a day ate as much as mice that were allowed to eat ... with the restricted eating hours gained less weight, had healthier livers and ...
... , THURSDAY, May 17 (HealthDay News) -- Smoking ... and 2010, but too many of them still light up, ... current cigarette use among U.S. teens decreased from nearly 12 ... dropped from nearly 40 percent to about 34 percent among ...
... protein result in a serious immune malfunction. Scientists used ... vital components of the immune system. Their results have ... journal of international scientific repute. Researchers at The ... University of Copenhagen have mapped how the XIAP protein ...
... have known for years that when the proteins RalA and ... of cancer. However, until this week, no study had explored ... essential step on the path to developing drugs to target ... involvement in prostate cancer, to shortened survival in squamous cell ...
... (HealthDay News) -- Mental distractions can act as a form ... volunteers were asked to complete a difficult or easy memory ... their arms. The participants perceived less pain when they were ... Using functional MRI, the German researchers also found that ...
Cached Medicine News:Health News:Preventing post-traumatic stress 2Health News:Preventing post-traumatic stress 3Health News:It's Not Just What You Eat, It's When You Eat, Mouse Study Finds 2Health News:Fewer Young Americans Smoking, Survey Finds 2Health News:Scientists study serious immune malfunction 2Health News:Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: